Adeoye Y. Olukotun, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 959 shares at $21.00 ($20K) on 2025-01-23, disclosed to the SEC on 2025-01-27.
Scheduled sale ($20k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ARWR | SELL | 2024-12-30 | $57K | — | Filing → |
| ARWR | SELL | 2023-03-06 | $741K | — | Filing → |
| ARWR | SELL | 2022-01-04 | $508K | — | Filing → |